 Connection
John Kinsella to Time Factors
This is a "connection" page, showing publications John Kinsella has written about Time Factors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.166 |
|
|
|
-
Jack ES, Shaw M, Harten JM, Anderson K, Kinsella J. Cardiovascular changes after achieving constant effect site concentration of propofol. Anaesthesia. 2008 Feb; 63(2):116-20.
Score: 0.034
-
Kinsella JP, Parker TA, Ivy DD, Abman SH. Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia. J Pediatr. 2003 Apr; 142(4):397-401.
Score: 0.025
-
Kinsella JP, Abman SH. Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia. J Pediatr. 2000 Jun; 136(6):717-26.
Score: 0.020
-
Deeney S, Howley LW, Hodges M, Liechty KW, Marwan AI, Gien J, Kinsella JP, Crombleholme TM. Impact of Objective Echocardiographic Criteria for Timing of Congenital Diaphragmatic Hernia Repair. J Pediatr. 2018 01; 192:99-104.e4.
Score: 0.017
-
Mansfield M, Russell D, Kenny GN, Kinsella J. An investigation of the effect of ondansetron on time to induction of anaesthesia with thiopentone and propofol. Eur J Anaesthesiol. 1997 Jan; 14(1):24-8.
Score: 0.016
-
Mourani PM, Sontag MK, Younoszai A, Miller JI, Kinsella JP, Baker CD, Poindexter BB, Ingram DA, Abman SH. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):87-95.
Score: 0.014
-
Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr. 1993 Jul; 123(1):103-8.
Score: 0.013
-
Cuthbertson BH, Campbell MK, Stott SA, Vale L, Norrie J, Kinsella J, Cook J, Brittenden J, Grant A. A pragmatic multi-centre randomised controlled trial of fluid loading and level of dependency in high-risk surgical patients undergoing major elective surgery: trial protocol. Trials. 2010 Apr 16; 11:41.
Score: 0.010
-
Storme L, Parker TA, Kinsella JP, Rairigh RL, Abman SH. Chronic hypertension impairs flow-induced vasodilation and augments the myogenic response in fetal lung. Am J Physiol Lung Cell Mol Physiol. 2002 Jan; 282(1):L56-66.
Score: 0.006
-
Ivy DD, Kinsella JP, Ziegler JW, Abman SH. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg. 1998 Apr; 115(4):875-82.
Score: 0.004
-
Ivy DD, Ziegler JW, Dubus MF, Fox JJ, Kinsella JP, Abman SH. Chronic intrauterine pulmonary hypertension alters endothelin receptor activity in the ovine fetal lung. Pediatr Res. 1996 Mar; 39(3):435-42.
Score: 0.004
-
Ziegler JW, Ivy DD, Fox JJ, Kinsella JP, Clarke WR, Abman SH. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Am J Physiol. 1995 Aug; 269(2 Pt 2):H473-9.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|